Justifying small-n research in scientifically amazing settings: challenging the notion that only "big-n" studies are worthwhile.
暂无分享,去创建一个
James Fiedler | Alan H Feiveson | A. Feiveson | R. Ploutz-Snyder | Robert J Ploutz-Snyder | J. Fiedler
[1] Bernard R. Rosner,et al. Fundamentals of Biostatistics. , 1992 .
[2] C. McCulloch,et al. Ethics and sample size. , 2005, American journal of epidemiology.
[3] Peter Bacchetti,et al. Current sample size conventions: Flaws, harms, and alternatives , 2010, BMC medicine.
[4] M. Segal,et al. Simple, Defensible Sample Sizes Based on Cost Efficiency , 2008, Biometrics.
[5] Andrew R Willan,et al. Optimal clinical trial design using value of information methods with imperfect implementation. , 2009, Health economics.
[6] L. Braitman. Confidence intervals assess both clinical significance and statistical significance. , 1991, Annals of internal medicine.
[7] Joseph F. Mudge,et al. Setting an Optimal α That Minimizes Errors in Null Hypothesis Significance Tests , 2012, PloS one.
[8] Simon Eckermann,et al. The Value of Value of Information , 2012, PharmacoEconomics.
[9] Steven G. Deeks,et al. Breaking Free of Sample Size Dogma to Perform Innovative Translational Research , 2011, Science Translational Medicine.
[10] Leonard E. Brahman. Confidence Intervals Assess Both Clinical Significance and Statistical Significance , 1991 .
[11] S. Goodman,et al. The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.